Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Pharmaceutical research, product lines, toll manufacturing More
Pharmaceuticals Division, Agrochemicals Division, Animal Health Division More
Isis Innovation is a wholly owned subsidiary of the University of Oxford, founded to exploit know-how arising out of research at one of the World's premier research institutions More
Commercial exploitation company of The University of Manchester More
Promote and facilitate the transfer of University-developed technology for society's use More
The Chinese University of Hong Kong is engaged in research over a broad front, and many of its research results can be of immediate benefit to society More
Western Arc offers technology for licensing as well as possibilities for collaborative research. More
NeuroDigm advances a new platform for chronic pain research and drug discovery with a biogenic animal model associated with new clinical methods of diagnosis More
Your selection
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us